Top Markets
#1 Zora Zora +33.71%
#2 SAFEcoin SAFEcoin +32.79%
#3 0G 0G +20.57%
#4 QuantixAI QuantixAI +19.34%
#5 Full Moon Full Moon +18.56%
#6 Axelar Axelar +17.33%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.59%
#8 VVS Finance VVS Finance +15.88%
#9 SkyAI SkyAI +13.81%
#10 Apertum Apertum +13.61%
Coin of the day
Zora Zora
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics, Inc.

ARTV
Rang in Aktien #12869
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm... Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.
Aktienkurs
$11.09
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$542.19M
Veränderung (1 Tag)
-7.12%
Veränderung (1 Jahr)
252.06%
Land
US
Handel Artiva Biotherapeutics, Inc. (ARTV)

Kategorie

Healthcare
Dividendenhistorie für Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (Aktienkürzel: ARTV) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Artiva Biotherapeutics, Inc. (ARTV) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH